The Sage Group is at JPM/BIO Partnering in San Francisco from 13-16 January, 2025! Please click here to setup a meeting!

Sage is representing Mateon Therapeutics, a US-based biopharma company focusing on Vascular Disrupting Agents (VDAs) for orphan oncology...